Marvel Biosciences Corp. (TSXV:MRVL)
Canada · Delayed Price · Currency is CAD 0.1350
-0.0100 (-6.90%)
Jan 20, 2026, 3:20 PM EST
Marvel Biosciences Market Cap
Marvel Biosciences has a market cap or net worth of CAD 8.41 million as of January 20, 2026. Its market cap has increased by 21.16% in one year.
Market Cap
8.41M
Enterprise Value
10.09M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.14
Market Cap Chart
Since July 13, 2021, Marvel Biosciences's market cap has decreased from 12.71M to 8.41M, a decrease of -33.82%. That is a compound annual growth rate of -8.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 19, 2026 | 8.41M | 7.41% |
| Dec 31, 2025 | 7.83M | 2.85% |
| Dec 31, 2024 | 7.61M | 139.21% |
| Dec 29, 2023 | 3.18M | -36.00% |
| Dec 30, 2022 | 4.97M | -43.47% |
| Dec 30, 2021 | 8.80M | -30.77% |
| Jul 13, 2021 | 12.71M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curaleaf Holdings | 2.85B |
| Green Thumb Industries | 2.61B |
| dentalcorp Holdings | 2.20B |
| Sienna Senior Living | 2.15B |
| Extendicare | 2.13B |
| Trulieve Cannabis | 2.02B |
| Cronos Group | 1.35B |
| Bright Minds Biosciences | 1.20B |